Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Aggressive Non-Hodgkin Lymphoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma by Clinical Course
Aggressive Non-Hodgkin Lymphoma

Hematologic Malignancy

Aggressive Non-Hodgkin Lymphoma

CI-CAN-00004411Explore in graph →

Hematologic182 active trials5 evidence items

NCIt: C9244

Overview
Statistics
Survival
Genomics7
Variants & evidence5
Drugs2
Trials648
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

648 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 182
Recruiting: 92
Ph III recruiting: 4
Growth YoY: +6.7%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (109)

StatusAll Active (any)Completed 262 Recruiting 104 Terminated 80 Unknown 75 Active Not Recruiting 62 Not Yet Recruiting 32 Withdrawn 25 Suspended 6 Approved For Marketing 1 No Longer Available 1

PhaseAll Early Phase 1 14 N/A 43 Phase 1 258 Phase 2 340 Phase 3 33 Phase 4 14

No study matches these filters